Cyanotech Corp (CYAN) 4.73 $CYAN
Cyanotech Names Gerry Watts as Chief Operations Officer
Business Wire - Mon Aug 18, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard "Gerry" Watts to fill a newly-created position as Chief Operations Officer, effective today.
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2015
Business Wire - Thu Aug 14, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2015, ended June 30, 2014.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2014
Business Wire - Fri Jun 27, 8:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2014, ended March 31, 2014.
Nasdaq stocks posting largest percentage decreases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Short Squeeze Starting in Cyanotech (CYAN) According to WealthMakers.com
M2 - Fri Feb 28, 8:34AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Cyanotech (NASDAQ: CYAN). The report highlights the short term bullish pattern that has emerged, bullish insider buying, the SqueezeTrigger Price of $5.40 and the fundamental valuation price target of $14.00 per share. Shares of CYAN crossed above their $5.40 SqueezeTrigger Price yesterday so the short squeeze is just beginning.
TerraX Closes Private Placement for $675,000
Marketwire - Wed Feb 12, 2:10PM CST
TerraX Minerals Inc. (TSX VENTURE: TXR)(FRANKFURT: TX0) has closed its previously announced non-brokered private placement of 1,500,000 units at $0.45 per unit, with two placees, for gross proceeds of $675,000. Each unit consists of one common share and one-half of one share purchase warrant, with each full warrant entitling the holder to purchase an additional common share at an exercise price of $0.51 per share until February 12, 2016. The shares and any shares acquired on the exercise of warrants will be subject to a hold period expiring on June 13, 2014. Finders' fees of $31,500 were paid with respect to this placement along with the issuance of 70,000 finders' warrants exercisable at $0.51 until February 12, 2016.
Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2014
Business Wire - Thu Feb 06, 7:00AM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the third quarter and first nine months of fiscal year 2014, ended December 31, 2013.
Marine Biotechnology - Global Strategic Business Report
M2 - Mon Jan 20, 3:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/rhp9th/marine) has announced the addition of the "Marine Biotechnology - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: - Marine Biomaterials - Marine Bioactive Substances - Others Major End-Use Applications also analyzed for the global market include: - Industrial Products - Health Care/Biotechnology - Consumer Products - Public Services & Infrastructure - Others The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY DYNAMICS 2. A REVIEW OF END-USE MARKETS/APPLICATIONS 3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW 4. MARINE BIOTECHNOLOGY - AN OVERVIEW 5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS - New Research Finding Reveals the Role of Opisthobranchs in Lignarenones Biosynthesis - Norwegian Researchers Explore Potential of Tunicate as a Source of Biofuel and Fish Feed - Scientists Unearth Medicinal Properties of Marine Enzyme, Bacillus Licheniformis - Norwegian Researchers Study Potential of Farmed Salmon Waste as Nutrients to Nourish Kelp and Mussel - Researchers Study Effectiveness of Alginate Supplementation on Weight Loss - Lamellarins Can Stop Cancer Drug Resistance: New Finding on Marine Natural Product - Evaluation of DHA and EPA Concentration in Algal Species - Study of Potential Applications of Delesseria Sanguinea - Scientists Use Bacteria Occurring in Marine Waters to Develop New Assays 6. PRODUCT INTRODUCTIONS/INNOVATIONS - Bluewave Marine Ingredients Launches AminoMarine Fish Protein Powder - Cyvex Nutrition Rolls Out Protomine Fish Protein Powder - Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient - Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging Products - DSM Unveils DHA plus EPA Product - Aqua Bio Technology Launches New Marine-Based Ingredients - La Prairie Launches Lifestyle Collection - Aqua Bio Technology Launches Zonase X Marine Ingredient - Frutarom USA to Introduce New Range of Marine Extracts - Biotech Marine Launches BioFA Anti-Aging Ingredient 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles 99 companies including many key and niche players such as: - Aker BioMarine - Aqua Bio Technology - Aquapharm Biodiscovery - CP Kelco - Cyanotech Corp. - Nutrex Hawaii - FMC Corp. - FMC BioPolymer - NovaMatrix - GlycoMar - Jazz Pharmaceuticals - Lonza Group - Marinova - New England Biolabs - oceanBASIS - PharmaMar - PML Applications - Prolume - BioLume? - Pronova BioPharma - Royal DSM N.V - Sea Run Holdings - SEPPIC - Biotech Marine - Tequesta BioVentures For more information visit http://www.researchandmarkets.com/research/rhp9th/marine About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Cyanotech Corporation names Walter B. Menzel as director
M2 - Mon Sep 09, 4:34AM CDT
The stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN), a microalgae technology company, announced on Friday the appointment of Walter B. Menzel as its director.
Cyanotech Stockholders Elect Walter B. Menzel as a Director
Business Wire - Fri Sep 06, 12:00PM CDT
Stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN) elected Walter B. Menzel as a Director at the Annual Meeting on August 29, 2013.
OTC Daily Alert Stock Watch Cyanotech Corporation (NASDAQ: CYAN)
WorldStockWire - Mon Sep 02, 5:16PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Nasdaq stocks posting largest volume decreases
AP - Tue Jul 09, 6:01PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
Cyanotech Corporation achieves improved net income of USD4.209m for fiscal 2013
M2 - Tue Jun 25, 6:23AM CDT
Health products company Cyanotech Corporation (Nasdaq Capital Market:CYAN) on Monday declared a net income of USD4.209m (USD0.74 per diluted share) for its fiscal year ended 31 March 2013.
WEALTHMAKERS.COM Issues Bearish Research Reports on CMCO, CTP, CYAN, DWRE, FLEX, GLT
M2 - Tue Jun 11, 11:09AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Columbus Mckinnon Corp (NASDAQ:CMCO), CTPartners Executive Search Inc (AMEX:CTP), Cyanotech Corp (NASDAQ:CYAN), Demandware Inc (NYSE
WRE), Flextronics International Ltd (NASDAQ:FLEX), P H Glatfelter Co (NYSE:GLT)
ENY, CYAN, IYY, IVV, HTM, PXLW Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jun 10, 4:27AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of GUGGENHEIM CANADIAN ENERGY I (NYSE:ENY), Cyanotech Corp (NASDAQ:CYAN), Ishares Dow Jones United States Total Market Index Fund (NYSE:IYY), Ishares S&P 500 (NYSE:IVV), US Geothermal Inc (AMEX:HTM), Pixelworks Inc (NASDAQ
XLW) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Cyanotech Names Gerry Watts as Chief Operations Officer
Business Wire - Mon Aug 18, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard "Gerry" Watts to fill a newly-created position as Chief Operations Officer, effective today.
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2015
Business Wire - Thu Aug 14, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2015, ended June 30, 2014.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2014
Business Wire - Fri Jun 27, 8:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2014, ended March 31, 2014.
Nasdaq stocks posting largest percentage decreases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Short Squeeze Starting in Cyanotech (CYAN) According to WealthMakers.com
M2 - Fri Feb 28, 8:34AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Cyanotech (NASDAQ: CYAN). The report highlights the short term bullish pattern that has emerged, bullish insider buying, the SqueezeTrigger Price of $5.40 and the fundamental valuation price target of $14.00 per share. Shares of CYAN crossed above their $5.40 SqueezeTrigger Price yesterday so the short squeeze is just beginning.
TerraX Closes Private Placement for $675,000
Marketwire - Wed Feb 12, 2:10PM CST
TerraX Minerals Inc. (TSX VENTURE: TXR)(FRANKFURT: TX0) has closed its previously announced non-brokered private placement of 1,500,000 units at $0.45 per unit, with two placees, for gross proceeds of $675,000. Each unit consists of one common share and one-half of one share purchase warrant, with each full warrant entitling the holder to purchase an additional common share at an exercise price of $0.51 per share until February 12, 2016. The shares and any shares acquired on the exercise of warrants will be subject to a hold period expiring on June 13, 2014. Finders' fees of $31,500 were paid with respect to this placement along with the issuance of 70,000 finders' warrants exercisable at $0.51 until February 12, 2016.
Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2014
Business Wire - Thu Feb 06, 7:00AM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the third quarter and first nine months of fiscal year 2014, ended December 31, 2013.
Marine Biotechnology - Global Strategic Business Report
M2 - Mon Jan 20, 3:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/rhp9th/marine) has announced the addition of the "Marine Biotechnology - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: - Marine Biomaterials - Marine Bioactive Substances - Others Major End-Use Applications also analyzed for the global market include: - Industrial Products - Health Care/Biotechnology - Consumer Products - Public Services & Infrastructure - Others The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY DYNAMICS 2. A REVIEW OF END-USE MARKETS/APPLICATIONS 3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW 4. MARINE BIOTECHNOLOGY - AN OVERVIEW 5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS - New Research Finding Reveals the Role of Opisthobranchs in Lignarenones Biosynthesis - Norwegian Researchers Explore Potential of Tunicate as a Source of Biofuel and Fish Feed - Scientists Unearth Medicinal Properties of Marine Enzyme, Bacillus Licheniformis - Norwegian Researchers Study Potential of Farmed Salmon Waste as Nutrients to Nourish Kelp and Mussel - Researchers Study Effectiveness of Alginate Supplementation on Weight Loss - Lamellarins Can Stop Cancer Drug Resistance: New Finding on Marine Natural Product - Evaluation of DHA and EPA Concentration in Algal Species - Study of Potential Applications of Delesseria Sanguinea - Scientists Use Bacteria Occurring in Marine Waters to Develop New Assays 6. PRODUCT INTRODUCTIONS/INNOVATIONS - Bluewave Marine Ingredients Launches AminoMarine Fish Protein Powder - Cyvex Nutrition Rolls Out Protomine Fish Protein Powder - Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient - Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging Products - DSM Unveils DHA plus EPA Product - Aqua Bio Technology Launches New Marine-Based Ingredients - La Prairie Launches Lifestyle Collection - Aqua Bio Technology Launches Zonase X Marine Ingredient - Frutarom USA to Introduce New Range of Marine Extracts - Biotech Marine Launches BioFA Anti-Aging Ingredient 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles 99 companies including many key and niche players such as: - Aker BioMarine - Aqua Bio Technology - Aquapharm Biodiscovery - CP Kelco - Cyanotech Corp. - Nutrex Hawaii - FMC Corp. - FMC BioPolymer - NovaMatrix - GlycoMar - Jazz Pharmaceuticals - Lonza Group - Marinova - New England Biolabs - oceanBASIS - PharmaMar - PML Applications - Prolume - BioLume? - Pronova BioPharma - Royal DSM N.V - Sea Run Holdings - SEPPIC - Biotech Marine - Tequesta BioVentures For more information visit http://www.researchandmarkets.com/research/rhp9th/marine About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Cyanotech Corporation names Walter B. Menzel as director
M2 - Mon Sep 09, 4:34AM CDT
The stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN), a microalgae technology company, announced on Friday the appointment of Walter B. Menzel as its director.
Cyanotech Stockholders Elect Walter B. Menzel as a Director
Business Wire - Fri Sep 06, 12:00PM CDT
Stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN) elected Walter B. Menzel as a Director at the Annual Meeting on August 29, 2013.
OTC Daily Alert Stock Watch Cyanotech Corporation (NASDAQ: CYAN)
WorldStockWire - Mon Sep 02, 5:16PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Nasdaq stocks posting largest volume decreases
AP - Tue Jul 09, 6:01PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
Cyanotech Corporation achieves improved net income of USD4.209m for fiscal 2013
M2 - Tue Jun 25, 6:23AM CDT
Health products company Cyanotech Corporation (Nasdaq Capital Market:CYAN) on Monday declared a net income of USD4.209m (USD0.74 per diluted share) for its fiscal year ended 31 March 2013.
WEALTHMAKERS.COM Issues Bearish Research Reports on CMCO, CTP, CYAN, DWRE, FLEX, GLT
M2 - Tue Jun 11, 11:09AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Columbus Mckinnon Corp (NASDAQ:CMCO), CTPartners Executive Search Inc (AMEX:CTP), Cyanotech Corp (NASDAQ:CYAN), Demandware Inc (NYSE
WRE), Flextronics International Ltd (NASDAQ:FLEX), P H Glatfelter Co (NYSE:GLT) ENY, CYAN, IYY, IVV, HTM, PXLW Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jun 10, 4:27AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of GUGGENHEIM CANADIAN ENERGY I (NYSE:ENY), Cyanotech Corp (NASDAQ:CYAN), Ishares Dow Jones United States Total Market Index Fund (NYSE:IYY), Ishares S&P 500 (NYSE:IVV), US Geothermal Inc (AMEX:HTM), Pixelworks Inc (NASDAQ
XLW) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: 
